Overcoming Drug Resistance in Advanced Prostate Cancer by Drug Repurposing

Overcoming Drug Resistance in Advanced Prostate Cancer by Drug Repurposing

Prostate cancer (PCa) is the second most common cancer in men. Common treatments include active surveillance, surgery, or radiation. Androgen deprivation therapy and chemotherapy are usually reserved for advanced disease or biochemical recurrence, such as castration-resistant prostate cancer (CRPC),...

Full description

Bibliographic Details
Main Authors: Hisham F. Bahmad, Timothy Demus, Maya M. Moubarak, Darine Daher, Juan Carlos Alvarez Moreno, Francesca Polit, Olga Lopez, Ali Merhe, Wassim Abou-Kheir, Alan M. Nieder, Robert Poppiti, Yumna Omarzai
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Medical Sciences
Subjects:
drug repurposing
androgen-deprivation therapy
prostate cancer
CRPC
Online Access:https://www.mdpi.com/2076-3271/10/1/15

Similar Items

Similar Items